Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Liquid Biopsies and Minimally-Invasive Diagnostics 2017

Shana Kelley's Biography



Shana Kelley, Professor, University of Toronto

Dr. Shana Kelley is a Distinguished Professor of Chemistry, Biochemistry, Pharmaceutical Sciences, and Biomedical Engineering at the University of Toronto. Dr. Kelley received her Ph.D. from the California Institute of Technology and was a NIH postdoctoral fellow at the Scripps Research Institute. The Kelley research group works in a variety of areas spanning bioanalytical chemistry, chemical biology and nanotechnology. Shana’s group has developed novel electrochemical sensors that enable ultrasensitive nucleic acids detection for clinical diagnostics, and has also investigated a new set of chemical probes that interact with intracellular nucleic acids. The Kelley labs also use nucleic acids as building blocks for complex nanomaterials assembly. Dr. Kelley’s work has been recognized with a variety of distinctions, including being named one of “Canada’s Top 40 under 40”, a NSERC E.W.R. Steacie Fellow, and the 2011 Steacie Prize. She has also been recognized with the Pittsburgh Conference Achievement Award, an Alfred P. Sloan Research Fellowship, a Camille Dreyfus Teacher-Scholar award, a NSF CAREER Award, a Dreyfus New Faculty Award, and was also named a “Top 100 Innovator” by MIT’s Technology Review. She is a founder of two molecular diagnostics companies, GeneOhm Sciences (acquired by Becton Dickinson in 2005) and Xagenic Inc.

Shana Kelley Image

Magnetic Ranking Cytometry: A New Tool for Liquid Biopsy and Subtyping of Rare Cells

Thursday, 5 October 2017 at 14:00

Add to Calendar ▼2017-10-05 14:00:002017-10-05 15:00:00Europe/LondonMagnetic Ranking Cytometry: A New Tool for Liquid Biopsy and Subtyping of Rare CellsLiquid Biopsies and Minimally-Invasive Diagnostics 2017 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

The heterogeneity and diverse phenotypes circulating tumor cells makes the analysis of these markers for liquid biopsy a challenge.  We have developed a new technique, magnetic ranking cytometry, that is able to separate CTCs based on phenotypic and genotypic properties.  In a single measurement, CTCs can be separated and classified according to protein expression, gene expression, or functional properties like chemotaxis.


Add to Calendar ▼2017-10-05 00:00:002017-10-06 00:00:00Europe/LondonLiquid Biopsies and Minimally-Invasive Diagnostics 2017Liquid Biopsies and Minimally-Invasive Diagnostics 2017 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com